Logo
x

Search category

Subscribe Now

Tappas Trial

Tracon Terminates its P-III TAPPAS Trial of TRC105 (carotuximab) + Votrient (pazopanib) for Advanced or Metastatic Angiosarcoma

Tracon Terminates its P-III TAPPAS Trial of TRC105 (carotuximab) + Votrient (pazopanib) for Advanced or Metastatic Angiosarcoma

  • April 15, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.